Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan 21;15(3):797.
doi: 10.3390/ma15030797.

Sorption Studies of Tetracycline Antibiotics on Hydroxyapatite (001) Surface-A First-Principles Insight

Affiliations

Sorption Studies of Tetracycline Antibiotics on Hydroxyapatite (001) Surface-A First-Principles Insight

Jiaming Song et al. Materials (Basel). .

Abstract

Owing to the limitations of traditional systemic drug delivery in the treatment of bone diseases with side effects on normal cells, the selection of materials with high affinities for bones, as targeting ligands to modify drug carriers, has become an important research topic. Tetracyclines (TCs) have an adsorption effect on hydroxyapatite (HAp). Thus, they can be used as bone-targeting ligands and combined with drug carriers. In this study, density functional theory is used to analyze the interaction mechanism of TC, oxytetracycline (OTC), chlortetracycline, and HAp. We calculate the electrostatic potential (ESP) and molecular orbitals to predict the possible binding sites of TCs on the HAp surface. The adsorption energy is used to compare the affinities of the three TCs to HAp. An independent gradient model analysis is performed to study the weak interaction between TCs and HAp. The coordination bond between TCs and the HAp surface is evaluated by conducting a charge density difference analysis. The results show that OTC has the highest affinity to HAp because the introduction of hydroxyl groups change the adsorption configuration of OTC. Thus, OTC adsorbed on HAp in a broken-line shape exposes more binding sites. This study provides a theoretical basis for TCs as bone-targeting ligands in treating bone diseases and in improving the safety of treatment by selecting different bone-targeting ligands.

Keywords: bone targeting; density functional theory; drug delivery; hydroxyapatite; tetracycline.

PubMed Disclaimer

Conflict of interest statement

We declare no financial or personal relationships with other people or organizations that can inappropriately influence our work.

Figures

Scheme 1
Scheme 1
Chemical structures of TC, OTC, and CTC.
Figure 1
Figure 1
ESP of HAp. The blue area represents a positive ESP exhibiting electrophilic properties, whereas the red area represents a negative ESP exhibiting nucleophilic properties.
Figure 2
Figure 2
ESPs of (A) TC, (B) OTC, and (C) CTC molecules (two-side view). The blue area represents a positive ESP exhibiting electrophilic properties, whereas the red area represents a negative ESP exhibiting nucleophilic properties.
Figure 3
Figure 3
HOMOs and LUMOs of HAp.
Figure 4
Figure 4
HOMOs and LUMOs of TC, OTC, and CTC.
Figure 5
Figure 5
Stable adsorption structures of (A) TC, (B) OTC, and (C) CTC on the HAp surface.
Figure 6
Figure 6
IGM between the two fragments of TCs and HAp.
Figure 7
Figure 7
Charge density difference analyses of (A) TC, (B) OTC, and (C) CTC (two side views).

References

    1. Wong S.K., Mohamad N.-V., Giaze T.R., Chin K.-Y., Mohamed N., Ima-Nirwana S. Prostate Cancer and Bone Metastases: The Underlying Mechanisms. Int. J. Mol. Sci. 2019;20:2587. doi: 10.3390/ijms20102587. - DOI - PMC - PubMed
    1. Cleeland C., Von Moos R., Walker M.S., Wang Y., Gao J., Chavez-MacGregor M., Liede A., Arellano J., Balakumaran A., Qian Y. Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer. Support. Care Cancer. 2016;24:3557–3565. doi: 10.1007/s00520-016-3154-x. - DOI - PMC - PubMed
    1. Rotman S., Grijpma D., Richards R., Moriarty F., Eglin D., Guillaume O. Drug delivery systems functionalized with bone mineral seeking agents for bone targeted therapeutics. J. Control. Release. 2018;269:88–99. doi: 10.1016/j.jconrel.2017.11.009. - DOI - PubMed
    1. Jiang T., Yu X., Carbone E.J., Nelson C., Kan H.M., Lo K.W.-H. Poly aspartic acid peptide-linked PLGA based nanoscale particles: Potential for bone-targeting drug delivery applications. Int. J. Pharm. 2014;475:547–557. doi: 10.1016/j.ijpharm.2014.08.067. - DOI - PubMed
    1. Gu W., Wu C., Chen J., Xiao Y. Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration. Int. J. Nanomed. 2013;8:2305–2317. doi: 10.2147/IJN.S44393. - DOI - PMC - PubMed

LinkOut - more resources